JP2023120246A5 - - Google Patents

Download PDF

Info

Publication number
JP2023120246A5
JP2023120246A5 JP2023094087A JP2023094087A JP2023120246A5 JP 2023120246 A5 JP2023120246 A5 JP 2023120246A5 JP 2023094087 A JP2023094087 A JP 2023094087A JP 2023094087 A JP2023094087 A JP 2023094087A JP 2023120246 A5 JP2023120246 A5 JP 2023120246A5
Authority
JP
Japan
Prior art keywords
pharmaceutical formulation
pcss
mixture
treatment
administered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023094087A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023120246A (ja
Filing date
Publication date
Priority claimed from PCT/US2018/020551 external-priority patent/WO2018160905A1/en
Application filed filed Critical
Publication of JP2023120246A publication Critical patent/JP2023120246A/ja
Publication of JP2023120246A5 publication Critical patent/JP2023120246A5/ja
Pending legal-status Critical Current

Links

JP2023094087A 2017-03-01 2023-06-07 セルライトを評価及び処置するための装置及び方法 Pending JP2023120246A (ja)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US201762465622P 2017-03-01 2017-03-01
US62/465,622 2017-03-01
US201762485705P 2017-04-14 2017-04-14
US62/485,705 2017-04-14
US201762607188P 2017-12-18 2017-12-18
US62/607,188 2017-12-18
PCT/US2018/020551 WO2018160905A1 (en) 2017-03-01 2018-03-01 Apparatus and method for assessing and treating cellulite
JP2019568589A JP7558654B2 (ja) 2017-03-01 2018-03-01 セルライトを評価及び処置するための装置及び方法

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2019568589A Division JP7558654B2 (ja) 2017-03-01 2018-03-01 セルライトを評価及び処置するための装置及び方法

Publications (2)

Publication Number Publication Date
JP2023120246A JP2023120246A (ja) 2023-08-29
JP2023120246A5 true JP2023120246A5 (enExample) 2024-08-26

Family

ID=61768443

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019568589A Active JP7558654B2 (ja) 2017-03-01 2018-03-01 セルライトを評価及び処置するための装置及び方法
JP2023094087A Pending JP2023120246A (ja) 2017-03-01 2023-06-07 セルライトを評価及び処置するための装置及び方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2019568589A Active JP7558654B2 (ja) 2017-03-01 2018-03-01 セルライトを評価及び処置するための装置及び方法

Country Status (18)

Country Link
US (4) US11123280B2 (enExample)
EP (2) EP4591945A2 (enExample)
JP (2) JP7558654B2 (enExample)
KR (3) KR20250021648A (enExample)
CN (2) CN115969318A (enExample)
AU (4) AU2018226820B2 (enExample)
BR (1) BR112019018277A2 (enExample)
CA (1) CA3055041A1 (enExample)
DK (1) DK3589204T3 (enExample)
ES (1) ES3036011T3 (enExample)
FI (1) FI3589204T3 (enExample)
HU (1) HUE072115T2 (enExample)
IL (2) IL301796A (enExample)
MX (2) MX2023008072A (enExample)
NZ (1) NZ756787A (enExample)
PL (1) PL3589204T3 (enExample)
PT (1) PT3589204T (enExample)
WO (1) WO2018160905A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4276180A3 (en) 2012-01-12 2024-01-10 Endo Global Ventures Clostridium histolyticum enzyme
KR20250021648A (ko) 2017-03-01 2025-02-13 엔도 오퍼레이션즈 리미티드 셀룰라이트를 평가하고 치료하기 위한 장치 및 방법
WO2018183582A2 (en) 2017-03-28 2018-10-04 Endo Ventures Limited Improved method of producing collagenase
WO2020021332A2 (en) 2018-07-12 2020-01-30 Endo Global Aesthetics Limited Injection techniques for the treatment of cellulite
WO2020021330A2 (en) 2018-07-12 2020-01-30 Endo Global Aesthetics Limited Injection techniques for the treatment of cellulite
WO2020058755A1 (en) 2018-09-18 2020-03-26 Endo Global Aesthetics Limited Compositions and methods for treating cellulite
AU2020204922B2 (en) * 2019-01-06 2025-04-24 Endo Global Aesthetics Limited Collagenase formulations and methods of producing the same
US20220095925A1 (en) 2019-03-13 2022-03-31 Blossom Innovations, LLC Devices, systems and methods for tissue analysis, location determination and therapy thereof using optical radiation
US11432733B2 (en) 2019-03-13 2022-09-06 Blossom Innovations Tissue detection devices, systems and methods
JP2022525112A (ja) 2019-03-13 2022-05-11 ブロッサム イノベーションズ エルエルシー 光放射を用いた組織分析、位置決定、およびその治療のためのデバイス、システム、および方法
CN113033528A (zh) * 2021-05-27 2021-06-25 明品云(北京)数据科技有限公司 一种反馈量表评估方法、系统、设备和介质

Family Cites Families (107)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3821364A (en) 1966-07-08 1974-06-28 Advance Biofactures Corp Process of producing collagenase
JPS5662229A (en) 1979-10-25 1981-05-28 Asahi Glass Co Ltd Electro-optical dimming panel
US4338300A (en) 1981-02-05 1982-07-06 The Regents Of The University Of California Use of purified clostridial collangenase in the treatment of Peyronie's disease
EP0115974B1 (fr) 1983-01-05 1988-09-07 Institut Pasteur Préparation à activité collagénolytique ayant une activité élevée et compositions pharmaceutiques la contenant
US4524065A (en) 1983-08-04 1985-06-18 Bio-Specifics N.V. Method for the prevention and treatment of scars with enzymes
US4645668A (en) 1983-08-04 1987-02-24 Biospecifics, Nv Method for the prevention and treatment of scars with enzymes
US5252461A (en) 1990-05-01 1993-10-12 The Regents Of The Univ. Of California Mixed immunoglobulins for detection of rheumatoid factors
CA2047306A1 (en) 1990-07-23 1992-01-24 Milan Holjevac Mutant bacterium clostridium histolyticum, a process for the obtaining thereof, and its use in the production of clostripain-free collagenase
US5393792A (en) 1991-11-20 1995-02-28 Advance Biofactures Of Curacao, N.V. High dosage topical forms of collagenase
US5462739A (en) 1991-11-21 1995-10-31 Yeda Research And Development Co., Ltd. Microdelivery device and method for enhanced drug administration to the eye
US5256140A (en) 1992-03-27 1993-10-26 Fallien Cosmeceuticals, Ltd. Composition for levelling skin
AU4644793A (en) 1992-06-22 1994-01-24 Trigen, Inc. Molecular cloning of the genes reponsible for collagenase production from clostridium histolyticum
JP3186881B2 (ja) 1993-02-18 2001-07-11 倉敷紡績株式会社 肝細胞の分離方法
US5332503A (en) 1993-04-16 1994-07-26 Baxter International Inc. Process for purifying collagenase
US5514340A (en) 1994-01-24 1996-05-07 Magnetix Biotechnology, Inc. Device for separating magnetically labelled cells
WO1996000283A1 (en) 1994-06-24 1996-01-04 Boehringer Mannheim Corporation A purified mixture of collagenases and two other proteases obtained from clostridium histolyticum
US5589171A (en) 1994-08-22 1996-12-31 Advance Biofactures Of Curacao Treatment of Dupuytren's disease with collagenase
CA2158822C (en) 1994-09-27 2008-12-23 Kusuki Nishioka Therapeutic agent for rheumatic disease
US6958150B2 (en) 1994-12-15 2005-10-25 Advance Biofactures Of Curacao, N.V. Reduction of adipose tissue
CA2213723A1 (en) 1995-03-16 1996-09-19 Claus Otto Markert New defined enzyme mixtures for obtaining cells and treating wounds
IT1279011B1 (it) 1995-06-15 1997-12-02 Ips Int Prod Services Apparecchiatura per la rilevazione e scelta dei trattamenti della cellulite
US5705170A (en) * 1995-10-24 1998-01-06 Plantech International, Inc. Herbal cellulite treatments
US5989888A (en) 1996-01-24 1999-11-23 Roche Diagnostics Corporation Purified mixture of collagenase I, collagenase II and two other proteases
AU5222498A (en) 1996-11-19 1998-06-10 Boehringer Mannheim Gmbh Type i recombinant clostridium histolyticum collagenase and its use for isolating cells and cell aggregates
US5830741A (en) 1996-12-06 1998-11-03 Boehringer Mannheim Corporation Composition for tissue dissociation containing collagenase I and II from clostridium histolyticum and a neutral protease
US5753785A (en) 1996-12-16 1998-05-19 Fina Technology, Inc. Production of E-B copolymers with a single metallocene catalyst and a single monomer
US6086872A (en) 1997-03-27 2000-07-11 Advance Biofactures Of Curacao, Nv Amelioration of dupuytren's disease
JPH10262658A (ja) 1997-03-28 1998-10-06 Kikkoman Corp ザルコシン・オキシダーゼの結晶、その製造方法及び三次元構造
WO1999017738A1 (en) 1997-10-03 1999-04-15 Lavipharm Laboratories, Inc. A prolamine-plant polar lipid composition, its method of preparation and applications thereof
GB9724802D0 (en) 1997-11-24 1998-01-21 Unilever Plc Antiperspirant or deodorant compoistions
US20020036328A1 (en) 1998-11-16 2002-03-28 William R. Richards, Jr. Offset drain fermi-threshold field effect transistors
FR2788682B1 (fr) * 1999-01-26 2001-04-06 Seb Sa Dispositif de thermographie
US6022539A (en) 1999-06-03 2000-02-08 Advance Biofactures Of Curacao Amelioration of peyronie's disease
RU2180002C2 (ru) 1999-08-16 2002-02-27 Пермское научно-производственное объединение "Биомед" Способ получения коллагеназы
AU6918700A (en) 1999-08-20 2001-03-19 Howard Murad Pharmaceutical compositions and methods for reducing the appearance of cellulite
US6280993B1 (en) 1999-08-24 2001-08-28 Ichiro Yamato Gene encoding class I collagenase
ITMI991894A1 (it) * 1999-09-09 2001-03-09 Carlo Ghisalberti Acido linoleico coniugato e trigliceride nuovi metodi di sintesi e d'uso
ES2364191T3 (es) 1999-09-24 2011-08-26 Proteon Therapeutics, Inc. Sistemas y métodos para abrir conductos biológicos obstruidos.
AU4477001A (en) 2000-04-18 2001-10-30 Peptron Inc. Injectable sustained release pharmaceutical composition and processes for preparing the same
JP2004528278A (ja) 2000-12-18 2004-09-16 ボード オブ レジェンツ,ザ ユニバーシティー オブ テキサス システム インサイチュヒドロゲルを用いた、局所領域の化学療法および放射線治療
WO2002060410A2 (en) 2001-01-30 2002-08-08 The Regents Of The University Of Michigan Methods for sustained release local delivery of drugs for ablation of unwanted tissue
WO2003004628A2 (de) 2001-07-02 2003-01-16 Nordmark Arzneinmittel Gmbh & Co. Kg Verfahren zur aufreinigung eines enzyms und hiernach hergestelltes, aufgereinigtes enzym sowie verwendung des enzyms
GB0124124D0 (en) 2001-10-08 2001-11-28 Medical Res Council Methods of treatment
CN101669841A (zh) * 2002-03-15 2010-03-17 总医院公司 通过受控冷却对脂肪组织进行选择性破坏的方法和装置
JP2003284553A (ja) 2002-03-28 2003-10-07 Seikagaku Kogyo Co Ltd 生理活性タンパク質
EP1538980B1 (en) * 2002-06-25 2017-01-18 Ultrashape Ltd. Device for body aesthetics
EP1433845A1 (en) 2002-12-23 2004-06-30 Georg-August-Universität Clostridium tetani collagenase and uses thereof
EP1462519A1 (en) 2003-03-24 2004-09-29 Boehringer Ingelheim Austria GmbH Method and devices for producing biomolecules
JP4205496B2 (ja) 2003-06-19 2009-01-07 三菱化学株式会社 新規カルボニル還元酵素及びこれをコードするdna、ならびにこれらを利用した光学活性アルコールの製造方法
EP2532742B1 (en) 2004-01-30 2018-08-08 Shire Pharmaceuticals Ireland Limited Recombinant arylsulfatase A for reducing galatosyl sulphatide levels in a subject
US8147428B2 (en) * 2004-04-16 2012-04-03 University Of Massachusetts Device and method for quantifying edema
ES2660172T3 (es) 2004-05-19 2018-03-21 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Composición inyectable que comprende desoxicolato de sodio
US7754230B2 (en) * 2004-05-19 2010-07-13 The Regents Of The University Of California Methods and related compositions for reduction of fat
US7355027B2 (en) 2004-06-16 2008-04-08 Dynport Vaccine Company Llc Bacillus anthracis protective antigen
EA011586B1 (ru) 2004-07-07 2009-04-28 Х. Лундбекк А/С Новый карбамилированный еро и способ его получения
JP2008505928A (ja) 2004-07-08 2008-02-28 アムジェン インコーポレーテッド 治療用ペプチド
CN101010274B (zh) 2004-08-30 2012-09-05 大赛璐化学工业株式会社 聚甘油单醚及其制造方法
US20150025420A1 (en) * 2004-10-06 2015-01-22 Guided Therapy Systems, Llc Ultrasound treatment device and methods of use
DE102004060075A1 (de) 2004-12-14 2006-07-06 Merck Patent Gmbh Verfahren zur Herstellung von Onium-Salzen mit Dialkylphosphat-, Dialkylphosphinat oder (O-Alkyl)-alkyl- oder Alkyl-phosphonat-Anionen mit geringem Halogenid-Gehalt
US7854929B2 (en) 2005-01-21 2010-12-21 The Research Foundation Of State University Of New York Method for treating lateral epicondylitis using collagenase
PL1846022T3 (pl) 2005-01-21 2016-06-30 Univ New York State Res Found Sposoby leczenia zarostowego zapalenia torebki stawowej
US20070224184A1 (en) 2006-02-22 2007-09-27 The Research Foundation Of The State University Of New York Method for treating cellulite
JP2006254876A (ja) 2005-03-18 2006-09-28 Hokkaido Univ L−トリプトファン製造法
US20060251581A1 (en) 2005-05-09 2006-11-09 Mcintyre Jon T Method for treatment of uterine fibroid tumors
US20070003541A1 (en) 2005-07-01 2007-01-04 Rodolfo Faudoa Methods and compositions for therapeutics
ITPD20050207A1 (it) 2005-07-07 2007-01-08 Fidia Farmaceutici Nuove composizioni farmaceutiche contenenti acido ialuronico e collagenas nel trattamento topico di ferite, ustioni ed ulcere
US20070031482A1 (en) * 2005-08-02 2007-02-08 Ceramoptec Industries, Ind. PDT treatment method for cellulites and cosmetic use
JP3122177U (ja) * 2005-09-28 2006-06-08 株式会社資生堂 セルライトの診断基準シート
US7811560B2 (en) 2006-01-30 2010-10-12 Auxilium Us Holdings, Llc Compositions and methods for treating collagen-mediated diseases
WO2007100590A2 (en) * 2006-02-22 2007-09-07 Auxilium Pharmaceuticals, Inc. Methods for treating cellulite
EA200802090A1 (ru) * 2006-03-31 2010-04-30 ДСМ АйПи АССЕТС Б.В. Новое применение соединений и комбинаций соединений для улучшения внешнего вида
WO2008100833A2 (en) 2007-02-13 2008-08-21 Auxilium International Holdings, Inc. Production of recombinant collagenases colg and colh in escherichia coli
US8617543B2 (en) 2007-02-14 2013-12-31 Yolare Pharmaceuticals, LLC Modified mutant collagenase and its use in fat melting and in scar reduction
WO2008138393A1 (en) * 2007-05-11 2008-11-20 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Gel useful for the delivery of cosmetic active ingredients
US9987221B2 (en) 2007-08-23 2018-06-05 Boston Scientific Scimed, Inc. Injectable hydrogel compositions
US20110262508A1 (en) 2007-11-07 2011-10-27 Paul Michael Watt Antimicrobial compositions, formulations and uses thereof
US20100159564A1 (en) 2007-11-30 2010-06-24 Dwulet Francis E Protease resistant recombinant bacterial collagenases
EP2130551B1 (en) 2008-06-02 2012-06-06 Roche Diagnostics GmbH Improved purification of collagenases from clostridium histolyticum liquid culture
US8236356B2 (en) 2008-06-11 2012-08-07 Roche Diagnostics Operations, Inc. Growth medium for Clostridium histolyticum
EP2306975A4 (en) 2008-07-21 2012-10-31 Otonomy Inc COMPOSITIONS WITH A TAXED RELEASE FOR MODULATING THE EARM STRUCTURE AND THE BORN IMMUNE SYSTEM, AND METHODS OF TREATING EAR OR DISEASE
US8380531B2 (en) 2008-07-25 2013-02-19 Invivodata, Inc. Clinical trial endpoint development process
US20110160617A9 (en) * 2008-10-22 2011-06-30 Allergan, Inc. Clinical assessment scales and methods
MX2011004666A (es) * 2008-11-11 2011-05-31 Sigma Tau Ind Farmaceuti Compuesto util para tratar celulitis.
CN102216454B (zh) 2008-11-19 2013-05-29 明治制果药业株式会社 结合了亲和标记物的融合胶原酶及其制造法
IT1397646B1 (it) 2009-12-15 2013-01-18 Seidita Collagenasi ricombinanti di c. histolyticum e metodo per la loro produzione.
WO2011109732A2 (en) 2010-03-05 2011-09-09 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Reverse thermal gels and uses therefor
US20130195828A1 (en) 2010-04-14 2013-08-01 Northwestern University Pharmaceutical Compositions and Methods for Digesting Atherosclerotic Plaques
US20120046576A1 (en) * 2010-08-19 2012-02-23 Medicis Pharmaceutical Corporation Mid-face aesthetic scale and related methods
WO2012031245A1 (en) 2010-09-03 2012-03-08 North Carolina Central University Biodegradable liquogel and ph sensitive nanocarriers
ES2385239B1 (es) 2010-09-30 2013-06-19 Proteos Biotech S.L.U. Uso de colagenasa g recombinante, colagenasa h recombinante y pz-peptidasa recombinante para el tratamiento de enfermedades que cursan con alteraciones del colágeno.
WO2012112940A1 (en) 2011-02-18 2012-08-23 Kythera Biopharmaceuticals, Inc. Treatment of submental fat
WO2012125948A1 (en) 2011-03-16 2012-09-20 Biospecifics Technologies Corp. Compositions and methods for producing clostridial collagenases
TWI461214B (zh) 2011-06-13 2014-11-21 Univ Chang Gung Biodegradable water-sensitive glue, a drug delivery system as a carrier thereof, and a pharmaceutical composition for the treatment and / or prevention of eye diseases
WO2013059263A1 (en) * 2011-10-17 2013-04-25 Sound Surgical Technologies, Llc Ultrasonic probe for treating cellulite
PT2768523T (pt) 2011-10-21 2019-08-29 Endo Global Ventures Processo para tratar ou reduzir a efp
EP4276180A3 (en) 2012-01-12 2024-01-10 Endo Global Ventures Clostridium histolyticum enzyme
BR112014018352A8 (pt) * 2012-01-27 2017-07-11 Revance Therapeutics Inc Métodos e escalas de avaliação para medição da severidade de rugas
CN104603616B (zh) * 2012-09-07 2017-03-08 株式会社资生堂 使用纤蛋白‑3和/或肌聚糖γ作为指标评价脂肪团的方法和评价脂肪团有效药物的方法
US20160000890A1 (en) 2013-03-15 2016-01-07 Biospecifics Technologies Corp. Thermosensitive hydrogel collagenase formulations
AU2014228477B2 (en) 2013-03-15 2019-05-23 Biospecifics Technologies Corporation Treatment method and product for uterine fibroids using purified collagenase
CA2905756C (en) * 2013-03-15 2016-11-29 Mary Kay Inc. Cosmetic compositions for reducing the appearance of cellulite or improving skin texture
CN103751102A (zh) 2014-01-15 2014-04-30 上海交通大学 一种胶原酶温敏水凝胶及其制备方法和应用
WO2015198150A2 (en) * 2014-06-27 2015-12-30 Medy-Tox Inc. Methods and compositions of bile acids and salts for reduction of fat
US11355247B2 (en) 2016-02-08 2022-06-07 OutcomeMD, Inc. Systems and methods for determining a wellness score, an improvement score, and/or an effectiveness score with regard to a medical condition and/or treatment
EP3532008B1 (en) * 2016-10-28 2021-08-11 Merz Pharma GmbH & Co. KGaA The cosmetic treatment of cellulite
KR20250021648A (ko) 2017-03-01 2025-02-13 엔도 오퍼레이션즈 리미티드 셀룰라이트를 평가하고 치료하기 위한 장치 및 방법
WO2018183582A2 (en) 2017-03-28 2018-10-04 Endo Ventures Limited Improved method of producing collagenase

Similar Documents

Publication Publication Date Title
JP2023120246A5 (enExample)
Wollina et al. Managing adverse events associated with botulinum toxin type A: a focus on cosmetic procedures
JP2016204396A5 (enExample)
JP2003520822A5 (enExample)
Pinelas et al. Effects of different doses of dexmedetomidine on anaesthetic induction with alfaxalone–a clinical trial
MX2023010728A (es) Un esteroide de c21-n-pirazolilo 19-nor c3,3-disustituido para el tratamiento de trastorno depresivo mayor.
JP2020510042A5 (enExample)
Ritota et al. Cushing's syndrome in postburn children following intralesional triamcinolone injection
HUE027236T2 (en) Methods for Adhesive Capsulitis Treatment
Shao et al. Treatment of infantile hemangioma by intralesional injection of propranolol combined with compound betamethasone
CN109172550B (zh) 一种复合麻醉药物
CN106074660A (zh) 乳香和没药在制备防治神经病理性痛疾病药物中的应用
Shelley et al. Urinary tract infection as a cause of lichen planus: metronidazole therapy
CN116747234A (zh) 一种螺内酯作为肌萎缩侧索硬化症治疗药物的新用途
RU2222319C2 (ru) Способ регионарной лимфостимуляции и обезболивания при лимфедеме нижних конечностей
Black et al. Streptomycin in tuberculous laryngitis
Krenn et al. Efficacy of solnatide to treat pulmonary permeability edema in SARS-CoV-2 positive patients with moderate to severe ARDS: A randomized controlled pilot-trial
Grover et al. Intralesional nail therapies
CN100558363C (zh) 一种治疗尖锐湿疣的药物组合物
Glassberg Csete et al. Young Donor Adipose-Derived Mesenchymal Stem Cell Therapy Rescues Bleomycin-Induced Pulmonary Fibrosis in an Aged Mouse Model in Part Through Regulation of microRNAs
Senna et al. Eyebrows and Eyelashes Regrowth Across Different SALT Response Thresholds in Patients with Alopecia Areata: Outcomes from the BRAVE AA Clinical Program
Kharghoria Intralesional nail therapies
Ständer et al. 718-Dupilumab reduces the number of lesions in adult patients with prurigo nodularis presenting with multiple lesion morphologies: pooled results from two phase 3 trials (LIBERTY-PN PRIME and PRIME2)
JPS6229529A (ja) 病疾患治療薬製造方法
Mehrotra Beyond beauty: botulinum toxin use in anal fissure